Merck Vioxx Communications With FDA Questioned By Senate Finance Cmte.
This article was originally published in The Pink Sheet Daily
Executive Summary
Sen. Grassley (R-Iowa) asks Merck to provide copies of its communications with FDA relating to Vioxx. The Finance chair is concerned about a possible “agreement” that may have allowed Vioxx to remain on the market longer than it would have otherwise.